Middle ear application of a sodium hyaluronate gel loaded with neomycin in a guinea pig model

Ear and Hearing

Volumn 30, Issue 1, 2009, Pages 81-89

  Saber, Amanj ^a,b   Laurell, Göran ^c   Bramer, Tobias ^d   Edsman, Katarina ^d   Engmér, Cecilia ^a,b   Ulfendahl, Mats ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; NEOMYCIN; DRUG VEHICLE;

ARTICLE; CELL LOSS; COCHLEA FENESTRA; CONTROLLED STUDY; CORTI ORGAN; DOSE RESPONSE; DRUG EFFICACY; DRUG RELEASE; DRUG TRANSPORT; ELECTRON MICROSCOPY; GUINEA PIG; HAIR CELL; INNER EAR; INNER EAR DISEASE; MIDDLE EAR; NONHUMAN; PHARMACODYNAMICS; SAFETY; ANIMAL; CELL DEATH; DRUG EFFECT; DRUG SCREENING; EAR DISEASE; GEL; INJECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VEHICLES;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EAR DISEASES; EAR, INNER; EAR, MIDDLE; GELS; GUINEA PIGS; HAIR CELLS, AUDITORY; HYALURONIC ACID; INJECTIONS; NEOMYCIN; ROUND WINDOW, EAR; VEHICLES;

EID: 64849084054     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e31818ff98e     Document Type: Article

References (41)

1. Alzamil, K. S., & Linthicum, F. H., Jr. (2000). Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol, 109, 30-32.
2. Anniko, M., Hellström, S., & Laurent, C. (1987). Reversible changes in inner ear function following hyaluronan application in the middle ear. Acta Otolaryngol Suppl, 442, 72-75. (Pubitemid 18018247)
3. Arnold, W., Senn, P., Hennig, M., et al. (2005). Novel slow and fast type drug release round window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurootol, 10, 53-63. (Pubitemid 40069615)
4. Arriaga, M. A., & Goldman, S. (1998). Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope, 108(Pt 1), 1682-1685; Comment in: Laryngoscope, 111, 1114-1115.
5. Atar, O., & Avraham, K. B. (2005). Therapeutics of hearing loss: expectations versus reality. Drug Discov Today, 10, 1323-1330. (Pubitemid 41416705)
6. Atlas, J. T., & Parnes, L. (1999). Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol, 20, 357-363. (Pubitemid 30120107)
7. Bagger-Sjöbäck, D. (1991). Sodium hyaluronate application to the open inner ear. An ultrastructural investigation. Am J Otol, 12, 35-39.
8. Banerjee, A., & Parnes, L. S. (2004). The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption. Otolaryngol Clin North Am, 37, 1035-1051. (Pubitemid 39335771)
9. Becvarovski, Z., Bojrab, D. I., Michaelides, E. M., et al. (2002). Round window gentamicin absorption: an in vivo human model. Laryngoscope, 112, 1610-1613. (Pubitemid 34977564)
10. Carpenter, A. M., Muchow, D., & Goycoolea, M. V. (1989). Ultrastructural studies of the human round window membrane. Arch Otolaryngol Head Neck Surg, 15, 585-590. (Pubitemid 19130299)
11. Chandrasekhar, S. S., Rubinstein, R. Y., Kwartler, J. A., et al. (2000). Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg, 122, 521-528.
12. Chelikh, L., Teixeira, M., Martin, C., et al. (2003). High variability of perilymphatic entry of neutral molecules through the round window. Acta Otolaryngol, 123, 199-202. (Pubitemid 36359791)
13. Coleman, J. K. M., Liilesunday, C., Jackson, R., et al. (2007). AM-111 protects against permanent hearing loss from impulse noise trauma. Hear Res 226, 70-78. (Pubitemid 46437288)
14. Duranti, F., Salti, G., Bovani, B., et al. (1998). Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histologic study. Dermatol Surg, 24, 1317-1325. (Pubitemid 29018221)
15. Endo, T., Nakagawa, T., Kita, T., et al. (2005). Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope, 115, 2016-2020. (Pubitemid 44391667)
16. Engel, F., Blatz, R., Kellner, J., et al. (1995). Breakdown of the round window membrane permeability barrier evoked by streptolysin O: possible etiologic role in development of sensorineural hearing loss in acute otitis media. Infect Immun, 63, 1305-1310.
17. Engmér, C., Laurell, G., Bagger-Sjöbäck, D., et al. (2008). Immunodefense of the round window. Laryngoscope, 118,1057-1062.
18. Engström, B., Bjurström, S., Janson, B., et al. (1987). An ultrastructural and functional study of the inner ear after administration of hyaluronan into the middle ear of the guinea pig. Acta Otolaryngol Suppl, 442, 66-71. (Pubitemid 18018246)
19. Goycoolea, M. V. (2001). Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol, 121, 437-447.
20. Goycoolea, M. V., & Lundman, L. (1997). Round window membrane. Structure function and permeability: a review. Microsc Res Tech, 36, 201-211.
21. Goycoolea, M. V., Paparella, M. M., Goldberg, B., et al. (1980). Permeability of the round window membrane in otitis media. Arch Otolaryngol Head Neck Surg, 106, 430-433. (Pubitemid 10071629)
22. Harada, T., Iwamori, M., Magai, Y., et al. (1986). Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol, 95, 404-408. (Pubitemid 16045168)
23. Hellström, S., Eriksson, P. O., Yoon, Y. J., et al. (1997). Interactions between the middle ear and the inner ear: bacterial products. Ann N Y Acad Sci, 830, 110-119. (Pubitemid 28045387)
24. Hellström, S., Johansson, U., & Anniko, M. (1988). Structure of the round window membrane. Acta Otolaryngol Suppl, 457, 33-42.
25. Kelly, R. M., Meyer, J. D., Matsuura, J. E., et al. (1999). In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm, 25, 15-20.
26. Laurell, G., Teixeira, M., Sterkers, O., et al. (2002). Local administration of antioxidants to the inner ear. Kinetics and distribution. Hear Res, 173, 198-209.
27. Laurent, C., Anniko, M., & Hellström, S. (1991). Hyaluronan applied to lesioned round window membrane is free from cochlear ototoxicity. Acta Otolaryngol, 111, 506-514.
28. Laurent, C., Hellstrom, S., & Anniko, M. (1988). Inner ear effects of exogenous hyaluronan in the middle ear of the rat. Acta Otolaryngol, 105, 273-280. (Pubitemid 18094704)
29. Laurent, C., Hellström, S., & Anniko, M. (1992). Cochlear effects of hyaluronan applied on ruptured round window membrane. Acta Otolaryngol Suppl, 493, 63-67.
30. Lundman, L. (1993). Round window membrane permeability. An experimental study. Thesis from the Department of Otorhinolaryngology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden; ISBN 91-628-0846-X.
31. Nordang, L., Linder, B., & Anniko, M. (2003). Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otol Neurotol, 24, 339-343. (Pubitemid 36337152)
32. Penha, R., & Escada, P. (2005). Round-window anatomical considerations in intratympanic drug therapy for inner-ear diseases. Int Tinnitus J, 11, 31-33. (Pubitemid 40917696)
33. Salt, A. N., & Ma, Y. (2001). Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res, 154, 88-97. (Pubitemid 32567538)
34. Selivanova, O. A., Gouveris, H., Victor, A., et al. (2005) Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol, 26, 890-895. (Pubitemid 41330703)
35. Selivanova, O. A., Maaurer, J., Ecke, U., et al. (2003). The effect of streptolysin-O and sodium hyaluronate on the permeability of the round window membrane in guinea pigs - an electrophysiologic study. Laryngorhinootologie 82, 235-239. (Pubitemid 36740986)
36. Sheppard, W. M., Wanamaker, H. H., Pack, A., et al. (2004) Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity. Otolaryngol Head Neck Surg, 131, 890-896. (Pubitemid 39575947)
37. Silverstein, H. (1999). Use of a new device, the micro wick to deliver medication to the inner ear. Ear Nose Throat J, 78, 595-598, 600.
38. Silverstein, H., Thompson, J., Rosenberg, S. I., et al. (2004). Silverstein Micro Wick. Otolaryngol Clin North Am, 37, 1019-1034.
39. Smith, B. M., & Myers, M. G. (1979). The penetration of gentamicin and neomycin into perilymph across the round window membrane. Otolaryngol Head Neck Surg, 87, 888-891.
40. Stern, R. (2004). Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol, 83, 317-325.
41. Yoon, Y. J., & Hellström, S. (2002). Ultrastructural characteristics of the round window membrane during pneumococcal otitis media in rat. J Korean Med Sci, 17, 230-235.